Tablets & Capsules

TC0416

Issue link: https://www.e-digitaleditions.com/i/666166

Contents of this Issue

Navigation

Page 54 of 71

+,*+'(6758&7,21()),&,(1&< ¬6$)(23(5$7,21 ¬5(/,$%/(3529(17(&+12/2*,(6 From pill coating and mixing operations to ethylene oxide (ETO) sterilization, Anguil thermal and catalytic oxidizers have been applied on a wide range of emission control applications in the pharmaceutical industry. As companies struggle to comply with the EPA's MACT standards or international regulations, our customers take comfort knowing that Anguil thoroughly understands their process. Four decades of experience in the industry enable us to efficiently solve your air pollution control problems. Contact us today to discuss your needs. Since 1978 www.anguil.com Committed to Cleaner Air. Tablets & Capsules April 2016 43 March 17, it was ready for 4 days of factory-acceptance testing (FAT), which two people from the pharma- ceutical manufacturer attended. Next, the half-million-dollar machine was expedited to the manufacturer's site on the East Coast. In addition, ACG dispatched two of its engineers to the site to help install the machine, qualify it, and provide other support. The site team worked around the clock to ensure the prod- uct would be ready on time. And it was. In fact, the team beat the deadline by 10 days, and on June 19, 2015, all three dosage strengths were ready for stability testing. "There were not any major issues that delayed our project. Everything worked. They set up and executed in the shortest possible time. It was a great coordination. They took the challenge just as we took it from our executive committee and they were committed to it." The R&D head had never done a project so quickly, and admitted to occasional bouts of concern. "You always think that something may break. One night you sleep and another night you don't. But I was less worried than I could have been because I found the ACG guys had a very similar mentality, and we com- plemented each other. I think that came from their experience working with the generic industry. They understood where they could help us." In addition to the capsule filler, ACG provided draft SOPs and quali- fication documents so the manufac- turer's people could populate the fields quickly. "That saved a lot of time. ACG gave us a very hard com- mitment that they would be able to deliver and they did. It was a very good experience working with those guys." T&C ACG North America, South Plainfield, NJ. Tel. 908 757 3425 Website: www.acg-world.com

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0416